Pharmacological inhibition of aberrant transcription factor complexes in inversion 16 acute myeloid leukemia

Research output: Contribution to journalEditorial

1 Citation (Scopus)

Abstract

Within the hematopoietic system, core binding factor beta (CBFβ) normally forms a complex with the master hematopoietic regulator, RUNX1 (1) and stabilizes its binding to DNA (2).
Original languageEnglish
Article number30
Number of pages5
JournalStem Cell Investigation
Volume5
DOIs
Publication statusPublished - 30 Sep 2018

Fingerprint

Dive into the research topics of 'Pharmacological inhibition of aberrant transcription factor complexes in inversion 16 acute myeloid leukemia'. Together they form a unique fingerprint.

Cite this